iMPROve Health’s Profit Surge After Arbitration Role — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- iMPROve Health lost over $2 million in 2022, more than a third of its revenue, prompting internal discussions about selling or merging the organization.
- iMPROve Health shifted to remote work, cut its budget, and abandoned its office to survive before winning a federal contract to arbitrate medical payment disputes.
- iMPROve Health now operates with a 70% profit margin and 13-fold revenue growth, fueled by its role in deciding high-stakes healthcare payment conflicts.
- Richard Murdock, a former iMPROve board member, confirmed the organization considered acquisition or merger due to severe financial strain in recent years.
Why it matters: Nonprofit arbitrators like iMPROve Health now wield significant financial and decision-making power in healthcare disputes without public oversight, turning a once-struggling entity into a highly profitable operation — a shift that changes the incentive structure of a key consumer protection law.
Ask SkimNews
